Literature DB >> 24397362

Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.

Martin Hansen1, Karina Phonekeo, James S Paine, Sebastian Leth-Petersen, Mikael Begtrup, Hans Bräuner-Osborne, Jesper L Kristensen.   

Abstract

N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor. We have prepared a series of 48 compounds with structural variations in both the phenethylamine and N-benzyl part of the molecule to determine the effects on receptor binding affinity and functional activity at 5-HT2A and 5-HT2C receptors. The compounds generally had high affinity for the 5-HT2A receptor with 8b having the highest affinity at 0.29 nM but with several other compounds also exhibiting subnanomolar binding affinities. The functional activity of the compounds was distributed over a wider range with 1b being the most potent at 0.074 nM. Most of the compounds exhibited low to moderate selectivity (1- to 40-fold) for the 5-HT2A receptor in the binding assays, although one compound 6b showed an impressive 100-fold selectivity for the 5-HT2A receptor. In the functional assay, selectivity was generally higher with 1b being more than 400-fold selective for the 5-HT2A receptor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24397362      PMCID: PMC3963123          DOI: 10.1021/cn400216u

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  35 in total

1.  Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease.

Authors:  Heinz Reichmann; Anja Bilsing; Reinhard Ehret; Wolfgang Greulich; Jörg B Schulz; Andreas Schwartz; Olivier Rascol
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

2.  1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.

Authors:  Thomas H McLean; Jason C Parrish; Michael R Braden; Danuta Marona-Lewicka; Alejandra Gallardo-Godoy; David E Nichols
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

3.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

Authors:  Francisco A Moreno; Christopher B Wiegand; E Keolani Taitano; Pedro L Delgado
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

5.  Pharmacological characterization of mouse GPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations.

Authors:  B Christiansen; K B Hansen; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

6.  Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.

Authors:  Karen H Adams; Elsebeth S Hansen; Lars H Pinborg; Steen G Hasselbalch; Claus Svarer; Søren Holm; Tom G Bolwig; Gitte M Knudsen
Journal:  Int J Neuropsychopharmacol       Date:  2005-04-01       Impact factor: 5.176

Review 7.  Ergot alkaloids--biology and molecular biology.

Authors:  Christopher L Schardl; Daniel G Panaccione; Paul Tudzynski
Journal:  Alkaloids Chem Biol       Date:  2006

8.  Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.

Authors:  Annamaria Colao; Roger Abs; David González Bárcena; Philippe Chanson; Wolfgang Paulus; David L Kleinberg
Journal:  Clin Endocrinol (Oxf)       Date:  2007-08-29       Impact factor: 3.478

Review 9.  Serotonin and migraine: biology and clinical implications.

Authors:  E Hamel
Journal:  Cephalalgia       Date:  2007-11       Impact factor: 6.292

10.  Activation of central 5HT2A receptors reduces the craniofacial nociception of rats.

Authors:  K Okamoto; H Imbe; A Kimura; T Donishi; Y Tamai; E Senba
Journal:  Neuroscience       Date:  2007-06-20       Impact factor: 3.590

View more
  24 in total

1.  Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors.

Authors:  Amy J Eshleman; Katherine M Wolfrum; John F Reed; Sunyoung O Kim; Robert A Johnson; Aaron Janowsky
Journal:  Biochem Pharmacol       Date:  2018-09-25       Impact factor: 5.858

2.  Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.

Authors:  Adam L Halberstadt; Jochem V F van der Zee; Muhammad Chatha; Mark A Geyer; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

3.  Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.

Authors:  Kuglae Kim; Tao Che; Ouliana Panova; Jeffrey F DiBerto; Jiankun Lyu; Brian E Krumm; Daniel Wacker; Michael J Robertson; Alpay B Seven; David E Nichols; Brian K Shoichet; Georgios Skiniotis; Bryan L Roth
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

4.  5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.

Authors:  Jennifer L Harmon; Lauren P Wills; Caitlin E McOmish; Elena Y Demireva; Jay A Gingrich; Craig C Beeson; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2016-01-19       Impact factor: 4.030

Review 5.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

6.  Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Authors:  Adam L Halberstadt; Muhammad Chatha; Stephen J Chapman; Simon D Brandt
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

7.  Pharmacological profile of novel psychoactive benzofurans.

Authors:  Anna Rickli; Simone Kopf; Marius C Hoener; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

8.  Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.

Authors:  Adam L Halberstadt; Ivan S Sindhunata; Kees Scheffers; Aaron D Flynn; Richard F Sharp; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-03-25       Impact factor: 5.250

Review 9.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.

Authors:  William E Fantegrossi; Bradley W Gray; Jessica M Bailey; Douglas A Smith; Martin Hansen; Jesper L Kristensen
Journal:  Psychopharmacology (Berl)       Date:  2014-09-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.